The hospital discharges for adnexa and eye diseases cases in Chile have shown a significant decline from 2013 to 2023. In 2013, the value stood at 22.52 thousand discharges, dropping to 10.47 thousand by 2023. This represents a considerable overall reduction. Year-on-year variations indicate multiple fluctuations, with notable percentages like a decrease of -33.05% in 2020 followed by an increase of 20.47% in 2021. The longer-term trend over the past five years shows a Compound Annual Growth Rate (CAGR) of -3.98%, illustrating a consistent downward trajectory.
Looking forward, the forecasted data suggests this declining trend will continue, with discharges projected to decrease further to 6.91 thousand by 2028. The forecasted five-year CAGR is -6.65%, indicating an accelerated decline compared to previous years.
Future trends to watch for:
- Advancements in medical treatments and technologies reducing the need for hospital discharges.
- Improved outpatient care and telemedicine services contributing to fewer hospital stays.
- Changes in healthcare policies and funding influencing hospital discharge rates.
- Health awareness and preventive measures that could impact the occurrence of adnexa and eye diseases.
